Home General Biotechnology Drug Patent Expirations in February 2010

Drug Patent Expirations in February 2010

Drug Patent Expirations in February 2010

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
ZAGAMMylansparfloxacin4,795,751Feb 4, 2010
TEVETENAbbotteprosartan mesylate5,185,351Feb 9, 2010
MYOVIEWGe Healthcaretechnetium tc-99m tetrofosmin kit5,045,302Feb 9, 2010
TEVETEN HCTAbbotteprosartan mesylate; hydrochlorothiazide5,185,351Feb 9, 2010
HYZAARMerckhydrochlorothiazide; losartan potassium5,138,069*PEDFeb 11, 2010
COZAARMercklosartan potassium5,138,069*PEDFeb 11, 2010
EXUBERAPfizerinsulin recombinant humanRE37872Feb 12, 2010
EXUBERAPfizerinsulin recombinant humanRE38385Feb 12, 2010
MEPRONGlaxosmithklineatovaquone4,981,874*PEDFeb 15, 2010
NITRO-DURKey Pharmsnitroglycerin5,186,938Feb 16, 2010
SANDIMMUNENovartiscyclosporine7,511,014Feb 16, 2010
ALDARAGracewayimiquimod4,689,338*PEDFeb 25, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply